Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials
Humboldt-Universität zu Berlin · Fraunhofer Institute for Translational Medicine and Pharmacology · +14 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
136
total citations
- FWCI
- 55.19
- Percentile
- 100%
- References
- 42
Citations per year
Authors
19- MMMarcus MaurerCorresponding
Humboldt-Universität zu Berlin, Fraunhofer Institute for Translational Medicine and Pharmacology, Freie Universität Berlin, Charité - Universitätsmedizin Berlin
- TBThomas B. Casale
University of South Florida
- SSSarbjit S. Saini
Johns Hopkins University, Johns Hopkins Medicine
- MBMoshe Ben‐Shoshan
McGill University Health Centre
- AMAna M. Giménez‐Arnau
Universitat Pompeu Fabra, Hospital del Mar Research Institute
Topics & keywords
Topics
Keywords
- Placebo
- Dupilumab
- Chronic urticaria
- Medicine
- Double blind
- Randomized controlled trial
- Phase (matter)
- Dermatology
No related works found for this paper.